Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Share News (SYNC)

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes
Get Live Data
97.20    -0.70 (-0.72%)
Bid:
97.20
Ask:
98.20
Spread: 1.00 (1.029%)
Market Cap: £591.16m
SYNC Live PriceLast checked at - London Stock Exchange

Intraday Syncona Share Chart

Syncona News

Syncona notes Autolus's first quarter loss widens amid higher costs
17 May 2024

Syncona notes Autolus's first quarter loss widens amid higher costs

(Alliance News) - Syncona Ltd on Friday noted that Autolus Therapeutics PLC reported an increased loss amid higher operating costs.

IN BRIEF: Syncona's Freeline gets positive results for Gaucher disease
9 May 2024

IN BRIEF: Syncona's Freeline gets positive results for Gaucher disease

Syncona Ltd on Thursday - London-based investor in healthcare companies - Says UK portfolio company Freeline Therapeutics Ltd presents positive new da...

Syncona reports positive findings from investee Freeline
9 May 2024

Syncona reports positive findings from investee Freeline

(Sharecast News) - Life science investor Syncona reported positive findings from its portfolio company Freeline Therapeutics on Thursday, after a phas...

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec
3 May 2024

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Syncona agrees to sell stake in investee company for GBP7.4 million
11 Apr 2024

Syncona agrees to sell stake in investee company for GBP7.4 million

(Alliance News) - Syncona Ltd on Thursday said it has reached an agreement to sell one of its portfolio companies to US biotechnology firm, Century Th...

IN BRIEF: Syncona notes investee Achilles's annual loss narrows
4 Apr 2024

IN BRIEF: Syncona notes investee Achilles's annual loss narrows

Syncona Ltd - London-based investor in healthcare companies - Notes that the loss of investee and clinical-stage biopharmaceutical company Achilles Th...

Syncona portfolio company Autolus posts widened loss for 2023
14 Mar 2024

Syncona portfolio company Autolus posts widened loss for 2023

(Alliance News) - Syncona Ltd on Thursday noted the 2023 results of one of its life science portfolio companies, which showed a widened loss and an in...

IN BRIEF: Freeline shareholders approve Syncona acquisition
12 Feb 2024

IN BRIEF: Freeline shareholders approve Syncona acquisition

Syncona Ltd - London-based investor in healthcare companies - Freeline Therapeutics Holdings PLC shareholders approve acquisition by Syncona.